# De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)

> **NCT03462095** · NA · UNKNOWN · sponsor: **National Research Center for Hematology, Russia** · enrollment: 350 (estimated)

## Conditions studied

- Precursor Cell Lymphoblastic Leukemia-Lymphoma

## Interventions

- **PROCEDURE:** Autologous HSCT

## Key facts

- **NCT ID:** NCT03462095
- **Lead sponsor:** National Research Center for Hematology, Russia
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2018-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03462095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03462095, "De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03462095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*